Navigation Links
Oncothyreon's PX-478 is effective in preclinical model of human lung cancer
Date:2/25/2008

BELLEVUE, WA, Feb. 25 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq - ONTY) (TSX - ONY) (the "Company") today announced the presentation of data demonstrating the effectiveness of PX-478 in a preclinical model of human lung cancer at the 8th Annual Targeted Therapies of the Treatment of Lung Cancer meeting of the International Association for the Study of Lung Cancer in Santa Monica, California. The data were presented on February 22, 2008, by Jorg J. Jacoby, Ph.D., Instructor, University of Texas M.D. Anderson Cancer Center, Houston. Oncothyreon's PX-478 is a small molecule inhibitor of hypoxia inducible factor (HIF)-1 alpha currently in a Phase 1 trial in patients with advanced metastatic cancer and lymphoma.

The study employed a model of lung cancer in mice, which closely mimics the disease in humans. Treatment with oral PX-478 for five days resulted in significant inhibition of tumor growth, marked reduction in lymph nodes metastases, decreased volume of pleural effusions, and significantly improved survival. PX-478 was effective in models of both non-small cell lung cancer and small cell lung cancer that express HIF-1 alpha.

"These data suggest that antagonism of HIF-1 alpha with PX-478 significantly inhibits the growth and spread of lung cancers expressing HI-1 alpha and will prove valuable in planning clinical trials of this novel agent," said Roy Herbst, M.D., Professor, Thoracic/Head & Neck Medical Oncology, M.D. Anderson Cancer Center, and senior author of the current study. "We look forward to conducting further studies of PX-478 in combination with other agents used in the treatment of these diseases, and to participating in future clinical trials of this highly promising drug candidate."

Enrollment is ongoing in the Phase 1 dose escalation trial of PX-478 in patients with advanced metastatic cancer and lymphoma. Clinical data from this trial are expected in the second half of 2008.

About PX-478

PX-478 is a n
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Phase III Trial Finds Pharmaxis Bronchitol Effective
2. New nanoparticle vaccine is more effective but less expensive
3. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
4. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
5. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
6. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
7. Free White Paper Available for Clinical Laboratory Managers: Effectively Isolating Anaerobic Bacteria
8. DNA sensors found to be an effective artificial nose
9. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
10. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
11. Genmab Announces Encouraging Preclinical Data for ofatumumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 OHAUS Corporation, a leading ... is set to release a new line of Water ... instruments. For over a century, the OHAUS brand has ... throughout the world. Now in North America, OHAUS ... Weighing to include water quality measurement. The OHAUS Starter ...
(Date:5/26/2015)... 2015  A simple blood test developed at the ... early Alzheimer,s disease is a step closer to being ... guidelines that are needed before a blood test could ... Alzheimer,s & Dementia . The guidelines establish protocols and ... that includes UNT Health Science Center. "If ...
(Date:5/26/2015)... Leading Regenerative Veterinary Medicine® Company ... relationship with Veterinary Growth Partners, a membership organization ... provide access to vital services to veterinary practices. ... as a dedicated partner in bringing stem cell ... and using stem cells natural abilities to promote ...
(Date:5/26/2015)... 26, 2015 Mr. Kevin Xu , President ... Barack Obama and President Bill Clinton ... loss of Dr. Rongxiang Xu , Kevin,s father. ... ahead of his time, Dr. Xu,s commitment to the advancement ... legacy that will not be forgotten. As a renowned life ...
Breaking Biology Technology:OHAUS Corporation to Release New Water Analysis Meters in 2015 2OHAUS Corporation to Release New Water Analysis Meters in 2015 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 3Dr. Rongxiang Xu, Beyond A Legend 2
... Sign Strategic Partnership in Molecular Diagnostics. Co-development of assays and co-distribution ... gains exclusive rights in microbiology,bioMerieux takes equity stake in Biocartis." /> ... MARCY L,ETOILE, France and LAUSANNE, Switzerland, Nov. 4, 2010 ... ...
... Nov. 4, 2010 Onda Corporation, the global leader ... introduced the latest additions to the hydrophone product family ... HFO-660 is a new fiber optic hydrophone system that ... emerging applications of HITU. It is complemented with the ...
... EDISON, N.J., Nov. 4, 2010 International Technidyne Corporation ... THOR ), announced today the completion of its ... private equity firm, in an all cash transaction valued ... leader in hemostasis management and Point-of-Care (POC) testing for ...
Cached Biology Technology:bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 2bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 3bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 4bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 5bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 6bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 7bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 8bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 9Onda Introduces a New Fiber Optic Hydrophone and Scanning Tank 2International Technidyne Corporation Acquired by Warburg Pincus 2International Technidyne Corporation Acquired by Warburg Pincus 3
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... sickening more than 100 people and listeria-contaminated cantaloupes killing ... food-borne illness and determine their sources has become a ... Oct. 14 in the journal Applied and Environmental ... University scientists, will enable government agencies and food companies ...
... South Florida (USF) College of Public College Health have shown ... earliest form of malaria parasites can lay dormant in red ... the antimalarial drug artesunate. The study, which appears Oct. ... suggests that this early-stage dormancy phenomenon contributes to the failure ...
... industry speakers will present at Interactive Response Technologies ... Philadelphia. Nearly 100 IRT professionals convene for this interactive ... in clinical trials - using IVR/IWR to collect and ... look to mitigate delays, minimize costs and increase overall ...
Cached Biology News:New test can precisely pinpoint food pathogens 2Dormant malaria parsites in red blood cells may contribute to treatment failure 2
... Fiberboard boxes are ideal for use in refrigerators, ... storage racks. Four vibrant colors allow for color coding ... allow liquid nitrogen drainage or promote cool air circulation. ... which holds 81 tubes. Box dimensions: 13 ...
RABBIT ANTI BACTERIAL HISTIDASE...
2,4-Dinitrophenyl hapten is conjugated to BSA (Bovine Serum Albumin) protein through lysine....
See product name for description....
Biology Products: